Sigma Planning Corp Acquires Shares of 23,369 Tempus AI, Inc. (NASDAQ:TEM)

Sigma Planning Corp acquired a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 23,369 shares of the company's stock, valued at approximately $1,323,000.

Several other institutional investors have also modified their holdings of TEM. NEA Management Company LLC acquired a new position in Tempus AI in the 2nd quarter valued at $160,048,000. Novo Holdings A S acquired a new stake in shares of Tempus AI in the second quarter valued at about $142,605,000. Revolution Growth Management Company Inc. acquired a new stake in shares of Tempus AI in the second quarter valued at about $128,133,000. ARK Investment Management LLC lifted its stake in shares of Tempus AI by 355.0% in the third quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company's stock worth $134,604,000 after buying an additional 1,855,459 shares in the last quarter. Finally, Alphabet Inc. acquired a new position in Tempus AI during the second quarter worth about $54,289,000.

Analysts Set New Price Targets

TEM has been the subject of a number of analyst reports. JPMorgan Chase & Co. upped their price objective on shares of Tempus AI from $42.00 to $47.00 and gave the company an "overweight" rating in a report on Wednesday, August 7th. Needham & Company LLC reissued a "buy" rating and issued a $47.00 price target on shares of Tempus AI in a research note on Wednesday, August 7th. Bank of America downgraded shares of Tempus AI from a "buy" rating to a "neutral" rating and raised their price target for the stock from $45.00 to $60.00 in a report on Wednesday, October 2nd. Piper Sandler reiterated a "neutral" rating and issued a $70.00 price objective (up from $40.00) on shares of Tempus AI in a report on Tuesday. Finally, Loop Capital raised their target price on Tempus AI from $48.00 to $57.00 and gave the stock a "buy" rating in a research note on Tuesday, October 15th. Three analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $54.22.

Tempus AI Stock Performance

Shares of TEM stock traded up $0.04 during mid-day trading on Wednesday, hitting $68.08. 1,068,597 shares of the stock were exchanged, compared to its average volume of 1,182,796. The firm's fifty day moving average price is $50.90. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. Tempus AI, Inc. has a 12-month low of $22.89 and a 12-month high of $79.49.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.